100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
1809002-40-1Dihydro Tofacitinib Citrate Impurity
● In Stock
| Catalogue No.: | VE008139 |
|---|---|
| CAS No.: | 1809002-40-1 |
| Mol. Formula: | C16H22N6O . C6H8O7 |
| Mol. Weight: | 506.51 g/mol |
Additional information on CAS 1809002-40-1
Parent drug
TofacitinibIUPAC Name
3-((3R, 4R)-3-((6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1, 2, 3-tricarboxylatePharmacopoeial Synonyms
N/AOther Synonyms
5,6-Dihydro Tofacitinib CitrateDescription
Dihydro Tofacitinib Citrate Impurity is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Tofacitinib.
Request a Quote
"*" indicates required fields
Other products related to Tofacitinib impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
![N,7-dimethyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-7-dimethyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-7H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N,7-dimethyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
Cat No. VE0011037
![N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-methyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine
Cat No. VE0011034
![3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](https://veeprho.com/wp-content/uploads/2022/08/3-4-methyl-3-methyl-7-nitroso-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-3-oxopropanenitri.png "3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile")
Tofacitinib
CAS No. N/A
Cat No. VE009894
![4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine](https://veeprho.com/wp-content/uploads/2022/08/4-chloro-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidine.png "4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine")
